Southern Michigan Bank & Trust’s AstraZeneca AZN Stock Holding History

Southern Michigan Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.1K	Hold	509	–	–	0.03%	152
2026 Q1	$98.6K	Buy	+509	New	+$98.1K	0.04%	142

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

Southern Michigan Bank & Trust's AZN Position: Q2 2026 in Review

Southern Michigan Bank & Trust held its AstraZeneca (AZN) position steady in Q2 2026 at 509 shares worth $95.1K. The position accounts for 0.03% of the portfolio, ranked #152.

Southern Michigan Bank & Trust first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $98.6K in Q1 2026. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Southern Michigan Bank & Trust held 509 shares of AstraZeneca worth $95.1K as of Q2 2026.
Southern Michigan Bank & Trust left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.03% of Southern Michigan Bank & Trust's portfolio in Q2 2026, its #152 holding.
Southern Michigan Bank & Trust first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
Southern Michigan Bank & Trust's AstraZeneca position peaked at $98.6K in Q1 2026.
1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Southern Michigan Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.